Literature DB >> 15758625

Cystic fibrosis: an overview.

Nelson L Turcios1.   

Abstract

Cystic fibrosis (CF) is one of the most common inherited disorders of white populations. The isolation and cloning of the gene in CF that encodes the production of a transport protein that acts as an apical membrane chloride channel, termed cystic fibrosis transmembrane conductance regulator (CFTR), have improved our understanding of the disorder's pathophysiology and has aided diagnosis, but has also revealed the disease's complexity. Gene replacement therapy is still far from being used in patients with CF, mostly because of difficulties in targeting the appropriate cells. Life expectancy of patients with this disorder has greatly improved over past decades because of better symptomatic treatment strategies. This article summarizes advances in understanding and treatment of CF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15758625     DOI: 10.1097/01.mcg.0000155140.63510.cd

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

1.  The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era.

Authors:  Avantika Mishra; Ronda Greaves; John Massie
Journal:  Clin Biochem Rev       Date:  2005-11

2.  Nasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. multivorans and B. cenocepacia.

Authors:  Gustavo M Bertot; Marcela A Restelli; Laura Galanternik; Rene C Aranibar Urey; Miguel A Valvano; Saúl Grinstein
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

3.  Differential expression of calcium-activated chloride channels (CLCA) gene family members in the small intestine of cystic fibrosis mouse models.

Authors:  Ina Leverkoehne; Hannah Holle; Friederike Anton; Achim D Gruber
Journal:  Histochem Cell Biol       Date:  2006-03-03       Impact factor: 4.304

4.  CFTR gene mutations in pancreatitis: Frequency and clinical manifestations in an Austrian patient cohort.

Authors:  Heinz Zoller; Margit Egg; Ivo Graziadei; Marc Creus; Andreas R Janecke; Judith Löffler-Ragg; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

5.  Air stacking: effects of Pilates mat exercises on muscle strength and on pulmonary function in patients with cystic fibrosis.

Authors:  Caroline Buarque Franco; Antonio Fernando Ribeiro; André Moreno Morcillo; Mariana Porto Zambon; Marina Buarque Almeida; Tatiana Rozov
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

Review 6.  Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis.

Authors:  Cecilia Velino; Francesca Carella; Alessio Adamiano; Maurizio Sanguinetti; Alberto Vitali; Daniele Catalucci; Francesca Bugli; Michele Iafisco
Journal:  Front Bioeng Biotechnol       Date:  2019-12-17

7.  Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis.

Authors:  Susan S Baker
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.